Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.

Increasing numbers of patients are starting antiretroviral treatment (ART) at advanced age or reaching advanced age while on ART. We compared baseline characteristics and ART outcomes of older adults (aged ≥55 years) vs. younger adults (aged 25-54 years) in routine care settings in South Africa.A mu...

Full description

Bibliographic Details
Main Authors: Geoffrey Fatti, Eula Mothibi, Graeme Meintjes, Ashraf Grimwood
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4065012?pdf=render
id doaj-d3392850646b41dfb0b398050703092a
record_format Article
spelling doaj-d3392850646b41dfb0b398050703092a2020-11-25T01:43:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e10027310.1371/journal.pone.0100273Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.Geoffrey FattiEula MothibiGraeme MeintjesAshraf GrimwoodIncreasing numbers of patients are starting antiretroviral treatment (ART) at advanced age or reaching advanced age while on ART. We compared baseline characteristics and ART outcomes of older adults (aged ≥55 years) vs. younger adults (aged 25-54 years) in routine care settings in South Africa.A multicentre cohort study of ART-naïve adults starting ART at 89 public sector facilities was conducted. Mortality, loss to follow-up (LTFU), immunological and virological outcomes until five years of ART were compared using competing-risks regression, generalised estimating equations and mixed-effects models.4065 older adults and 86,006 younger adults were included. There were more men amongst older adults; 44.7% vs. 33.4%; RR = 1.34 (95% CI: 1.29-1.39). Mortality after starting ART was substantially higher amongst older adults, adjusted sub-hazard ratio (asHR) = 1.44 over 5 years (95% CI: 1.26-1.64), particularly for the period 7-60 months of treatment, asHR = 1.73 (95% CI: 1.44-2.10). LTFU was lower in older adults, asHR = 0.87 (95% CI: 0.78-0.97). Achievement of virological suppression was greater in older adults, adjusted odds ratio = 1.42 (95% CI: 1.23-1.64). The probabilities of viral rebound and confirmed virological failure were both lower in older adults, adjusted hazard ratios = 0.69 (95% CI: 0.56-0.85) and 0.64 (95% CI: 0.47-0.89), respectively. The rate of CD4 cell recovery (amongst patients with continuous viral suppression) was 25 cells/6 months of ART (95% CI: 17.3-33.2) lower in older adults.Although older adults had better virological outcomes and reduced LTFU, their higher mortality and slower immunological recovery warrant consideration of age-specific ART initiation criteria and management strategies.http://europepmc.org/articles/PMC4065012?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Geoffrey Fatti
Eula Mothibi
Graeme Meintjes
Ashraf Grimwood
spellingShingle Geoffrey Fatti
Eula Mothibi
Graeme Meintjes
Ashraf Grimwood
Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.
PLoS ONE
author_facet Geoffrey Fatti
Eula Mothibi
Graeme Meintjes
Ashraf Grimwood
author_sort Geoffrey Fatti
title Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.
title_short Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.
title_full Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.
title_fullStr Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.
title_full_unstemmed Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.
title_sort antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in south africa.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Increasing numbers of patients are starting antiretroviral treatment (ART) at advanced age or reaching advanced age while on ART. We compared baseline characteristics and ART outcomes of older adults (aged ≥55 years) vs. younger adults (aged 25-54 years) in routine care settings in South Africa.A multicentre cohort study of ART-naïve adults starting ART at 89 public sector facilities was conducted. Mortality, loss to follow-up (LTFU), immunological and virological outcomes until five years of ART were compared using competing-risks regression, generalised estimating equations and mixed-effects models.4065 older adults and 86,006 younger adults were included. There were more men amongst older adults; 44.7% vs. 33.4%; RR = 1.34 (95% CI: 1.29-1.39). Mortality after starting ART was substantially higher amongst older adults, adjusted sub-hazard ratio (asHR) = 1.44 over 5 years (95% CI: 1.26-1.64), particularly for the period 7-60 months of treatment, asHR = 1.73 (95% CI: 1.44-2.10). LTFU was lower in older adults, asHR = 0.87 (95% CI: 0.78-0.97). Achievement of virological suppression was greater in older adults, adjusted odds ratio = 1.42 (95% CI: 1.23-1.64). The probabilities of viral rebound and confirmed virological failure were both lower in older adults, adjusted hazard ratios = 0.69 (95% CI: 0.56-0.85) and 0.64 (95% CI: 0.47-0.89), respectively. The rate of CD4 cell recovery (amongst patients with continuous viral suppression) was 25 cells/6 months of ART (95% CI: 17.3-33.2) lower in older adults.Although older adults had better virological outcomes and reduced LTFU, their higher mortality and slower immunological recovery warrant consideration of age-specific ART initiation criteria and management strategies.
url http://europepmc.org/articles/PMC4065012?pdf=render
work_keys_str_mv AT geoffreyfatti antiretroviraltreatmentoutcomesamongstolderadultsinalargemulticentrecohortinsouthafrica
AT eulamothibi antiretroviraltreatmentoutcomesamongstolderadultsinalargemulticentrecohortinsouthafrica
AT graememeintjes antiretroviraltreatmentoutcomesamongstolderadultsinalargemulticentrecohortinsouthafrica
AT ashrafgrimwood antiretroviraltreatmentoutcomesamongstolderadultsinalargemulticentrecohortinsouthafrica
_version_ 1725033371978956800